Dana Elizabeth Pepe, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter-Related Infections | 1 | 2020 | 239 | 0.640 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 258 | 0.610 |
Why?
|
| Epidemics | 1 | 2019 | 481 | 0.520 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 781 | 0.510 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 978 | 0.430 |
Why?
|
| Disease Outbreaks | 5 | 2022 | 1709 | 0.400 |
Why?
|
| Psychiatry | 1 | 2021 | 1597 | 0.360 |
Why?
|
| Students, Medical | 1 | 2019 | 1740 | 0.310 |
Why?
|
| Hospitals | 1 | 2020 | 3290 | 0.310 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 4810 | 0.250 |
Why?
|
| Monkeypox | 1 | 2022 | 51 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2019 | 5556 | 0.190 |
Why?
|
| Connecticut | 1 | 2020 | 363 | 0.190 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 92 | 0.190 |
Why?
|
| Acinetobacter Infections | 1 | 2020 | 76 | 0.190 |
Why?
|
| Urinary Catheterization | 1 | 2020 | 194 | 0.180 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2019 | 116 | 0.180 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 735 | 0.170 |
Why?
|
| Catheters | 1 | 2020 | 347 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2021 | 2064 | 0.150 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2019 | 390 | 0.130 |
Why?
|
| Infection Control | 1 | 2021 | 959 | 0.120 |
Why?
|
| Meningitis, Fungal | 1 | 2012 | 3 | 0.120 |
Why?
|
| Ascomycota | 1 | 2012 | 72 | 0.110 |
Why?
|
| Cross Infection | 1 | 2021 | 1412 | 0.110 |
Why?
|
| Aspergillus fumigatus | 1 | 2012 | 149 | 0.110 |
Why?
|
| Drug Contamination | 1 | 2012 | 151 | 0.110 |
Why?
|
| Lung Transplantation | 1 | 2020 | 1152 | 0.100 |
Why?
|
| Methylprednisolone | 1 | 2012 | 401 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2020 | 2147 | 0.100 |
Why?
|
| Inpatients | 1 | 2021 | 2207 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3558 | 0.090 |
Why?
|
| Education, Medical | 1 | 2019 | 1683 | 0.080 |
Why?
|
| Pandemics | 2 | 2022 | 7089 | 0.070 |
Why?
|
| Risk Factors | 3 | 2021 | 69553 | 0.070 |
Why?
|
| Monkeypox virus | 1 | 2022 | 32 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2125 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 16008 | 0.060 |
Why?
|
| Equipment Reuse | 1 | 2022 | 45 | 0.060 |
Why?
|
| Decontamination | 1 | 2022 | 69 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2022 | 258 | 0.050 |
Why?
|
| Humans | 8 | 2022 | 708843 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2021 | 23284 | 0.050 |
Why?
|
| Acinetobacter baumannii | 1 | 2020 | 99 | 0.050 |
Why?
|
| Carbapenems | 1 | 2020 | 129 | 0.040 |
Why?
|
| Sputum | 1 | 2020 | 472 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2020 | 369 | 0.040 |
Why?
|
| Health Facilities | 1 | 2020 | 450 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 597 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 1900 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 15538 | 0.030 |
Why?
|
| Tennessee | 1 | 2012 | 125 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2012 | 315 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2012 | 245 | 0.030 |
Why?
|
| Pharmacies | 1 | 2012 | 140 | 0.030 |
Why?
|
| Injections, Epidural | 1 | 2012 | 191 | 0.030 |
Why?
|
| Aspergillosis | 1 | 2012 | 235 | 0.030 |
Why?
|
| Massachusetts | 1 | 2022 | 8712 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12863 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 16306 | 0.010 |
Why?
|
| United States | 1 | 2022 | 67165 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 213752 | 0.010 |
Why?
|
| Male | 2 | 2020 | 349524 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 58184 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 161488 | 0.000 |
Why?
|
| Adult | 1 | 2012 | 211041 | 0.000 |
Why?
|
| Female | 1 | 2012 | 375205 | 0.000 |
Why?
|